A gene that scientific dogma insists is inactive in adults actually plays a vital role in preventing the underlying cause of most heart attacks and strokes, researchers at the University of Virginia School of Medicine have determined. The discovery opens a new avenue for battling those deadly conditions, and it raises the tantalizing prospect that doctors could use the gene to prevent or delay at least some of the effects of aging.
“Finding a way to augment the expression of this gene in adult cells may have profound implications for promoting health and possibly reversing some of the detrimental effects with aging,” said researcher Gary K. Owens, PhD, director of UVA’s Robert M. Berne Cardiovascular Research Center.
Unexpected Protective Effect
The gene, Oct4, plays a key role in the development of all living organisms, but scientists have, until now, thought it was permanently inactivated after embryonic development. Some controversial studies have suggested it might have another function later in life, but the UVA researchers are the first to provide conclusive evidence of that: Owens and his colleagues have determined the gene plays a critical protective role during the formation of atherosclerotic plaques inside blood vessels. The rupturing of these plaques is the underlying cause of many heart attacks and strokes.
The researchers found that Oct4 controls the movement of smooth muscle cells into protective fibrous “caps” inside the plaques – caps that make the plaques less likely to rupture. The researchers also have provided evidence that the gene promotes many changes in gene expression that are beneficial in stabilizing the plaques.
This is exciting, because studies suggest that it may be possible to develop drugs or other therapeutic agents that target the Oct4 pathway as a means to reduce the incidence of heart attacks or stroke. “Our findings have major implications regarding possible novel therapeutic approaches for promoting stabilization of atherosclerotic plaques,” said Olga A. Cherepanova, PhD, a senior research scientist in Owens’ lab.
One surprising finding from UVA’s research: When the researchers blocked the effect of Oct4 in mice, they thought the atherosclerotic plaques might become smaller, because of the reduced number of smooth muscle cells inside. Instead, the plaques grew larger, less stable and more dangerous, stuffed with lipids, dead cells and other damaging components.
Advancing Regenerative Medicine
While UVA’s research has focused on how Oct4 offers cardiovascular protection, Owens and his colleagues believe the gene could also prove critical to the field of regenerative medicine, which investigates the growth and replacement of tissues and organs. The researchers believe that Oct4 and its family of target genes are activated in other somatic cells – the non-reproductive cells in the body – and play a key role in the cells’ ability to repair damage and heal wounds. Studies to test this are under way in Owens’ lab.
Oct4 is one of the “stem cell pluripotency factors” described by Shinya Yamanaka, MD, PhD, for which he received the 2012 Nobel Prize. His lab and many others have shown that artificial over-expression of Oct4 within somatic cells grown in a lab dish is essential for reprogramming these cells into induced pluripotential stem cells, which can then develop into any cell type in the body or even an entire organism.
The UVA researchers suspect that at least some of the detrimental effects of aging, including the increased possibility of a plaque rupture, stem from a decrease in the body’s ability to reactivate Oct4. “Finding a way to reactivate this pathway may have profound implications for health and aging,” Owens said. “We think this is just the tip of the iceberg for controlling plasticity of somatic cells, and this could impact many human diseases and the field of regenerative medicine. Who knows, this may end up being the ‘fountain-of-youth gene,’ a way to revitalize old and worn-out cells. Only time will tell.”
Learn more: Gene helps prevent heart attack, stroke — and may offer way to block effects of aging
The Latest on: Oct4 gene
[google_news title=”” keyword=”Oct4 gene” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Oct4 gene
- Generative A.I. Arrives in the Gene Editing World of CRISPRon April 21, 2024 at 5:00 pm
The physical structure of OpenCRISPR-1, a gene editor created by A.I. technology from Profluent.Credit...Video by Profluent Bio Supported by By Cade Metz Has reported on the intersection of A.I ...
- Thousands of passengers affected as Princess Cruises delays new shipon April 19, 2024 at 10:44 am
When it launches, Star Princess will be the second vessel in Princess' long-awaited new Sphere Class of ships. Under development for more than six years, the Sphere Class includes the just-unveiled ...
- Body of bumbling train robber Elmer McCurdy finally laid to rest after 66 years | Only in Oklahomaon April 19, 2024 at 7:00 am
Following his death, McCurdy's body toured the country in sideshows until fun house owners finally realized they weren't dealing with a wax body.
- Bishop, Elvin Eugene "Gene"on April 18, 2024 at 5:00 pm
Elvin Eugene "Gene" Bishop, born January 2, 1932, in Broad Shoals, Sowers, VA, peacefully departed this life surrounded by loved ones on Friday, April 19, 2024. Gene was preceded in death by son ...
- Kiss sells song catalog for more than $300M to company co-founded by ABBA memberon April 4, 2024 at 10:41 am
When the band’s current lineup — founders Paul Stanley and Gene Simmons as well as guitarist Tommy Thayer and drummer Eric Singer — took the stage at the final night of their farewell tour ...
- Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsighton April 4, 2024 at 7:31 am
According to DelveInsight's analysis, the growth of the gene therapies market in ophthalmology is expected to be mainly driven by the increasing prevalence of eye disease, rise in awareness and ...
- YKT6 gene variants cause a new neurological disorder, finds studyon April 1, 2024 at 5:00 pm
A recent collaborative study has discovered rare variants in the YKT6 gene as the cause of a new neurological disorder characterized by developmental delays along with severe progressive liver ...
- Roadmap to embryo implantation: clues from mouse modelson March 19, 2024 at 4:54 am
These processes are coordinated by many transcription factors, including OCT4, SOX2, NANOG ... many evolutionarily conserved developmental genes, such fibroblast growth factors, bone morphogenic ...
- Going vegetarian? The dietary choice may be influenced by your genes.on December 20, 2023 at 12:41 am
It is unclear how these genes may influence people's choice to be vegetarian or the underlying physiology behind it. However, the findings, published Wednesday (Oct. 4) in the journal PLOS One ...
- Epigenetics Research Newson November 28, 2023 at 4:00 pm
Mar. 28, 2024 — A research consortium provides evidence that social behavior and social status are reflected at the molecular level of gene activation (epigenome) in juvenile and adult free ...
via Bing News